CP
CannaPharmaRX, Inc.
CPMD · OTC
$0.00 +0.00% (+$0.00)
1M -16.67%
Market Cap $1.36M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0
100.0% downside
Current Price
$0.002
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CPMD is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.80x
P/FCF 5.36x
P/E N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
26 /100
Weak Gross margin 80.67%
FCF margin 14.91%
Net margin 666.19%
Quality
62 /100
Average ROIC 25.89%
Asset turnover 0.25x
ROA 164.22%
Debt
0 /100
High Current ratio 0.04x
Int. coverage -5.22x
Debt/Equity N/A
Stability
25 /100
Unstable Beta 0.47x
Profitable years 0
EPS volatility 181.69%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CPMD
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Constantine Nkafu
Employees
26
Headquarters
Cremona